Halozyme Therapeutics Inc (NASDAQ:HALO) concluded the trading at $53.85 on Wednesday, June 04 with a rise of 1.01% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 14.29. Considering stock’s 52-week price range provides that HALO hit a
Halozyme Therapeutics Inc (NASDAQ:HALO) traded at $56.07 at close of the session on Friday, May 30 and made an upward move of 2.45% on its previous day’s price. Halozyme Therapeutics Inc has a market cap of $6.91 billion and is expected to release its quarterly
The trading price of Halozyme Therapeutics Inc (NASDAQ:HALO) closed lower on Tuesday, May 27, and closing at $54.42, -0.22% lower than its previous close. The company’s P/E ratio in the trailing 12-month period was 14.44. In examining the 52-week price action we see that the
Halozyme Therapeutics Inc (NASDAQ:HALO) price on Thursday, May 22, fall -0.33% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $53.75. A look at the stock’s price movement, the close in the last trading session was $53.93. The
Halozyme Therapeutics Inc (NASDAQ:HALO) traded at $48.91 at last check on current trade day and made a downward move of -26.54% on its previous day’s price. Halozyme Therapeutics Inc has a market cap of $6.03 billion and is expected to release its quarterly earnings report
The trading price of Halozyme Therapeutics Inc (NASDAQ:HALO) floating higher at last check on current market day and closing at $68.25, 14.95% higher than its previous close. The company’s P/E ratio in the trailing 12-month period was 19.88. In examining the 52-week price action we
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.